Empaone-L 25/5 Tablet

Empaone-L 25/5 Tablet is a prescription diabetes medicine that combines empagliflozin 25 mg and linagliptin 5 mg in each tablet. It belongs to two blood sugar–lowering classes: an SGLT2 inhibitor and a DPP-4 inhibitor. Empaone-L 25/5 Tablet is used, along with diet and exercise, to help improve blood sugar control in adults with type 2 diabetes. Because it contains the higher empagliflozin strength used in this brand line, it is chosen when a doctor wants a stronger glucose-lowering effect than Empaone-L 10/5 Tablet can provide.

How it works: Empagliflozin helps the kidneys remove extra sugar through the urine, which lowers blood glucose. Linagliptin helps increase the body’s own insulin response after meals and reduces sugar made by the liver, and this tablet combines both actions in one dose.

Empaone-L 25/5 Tablet is the higher-strength sibling of Empaone-L 10/5 Tablet because it contains 25 mg of empagliflozin instead of 10 mg, while linagliptin stays at 5 mg. That means the tablet may provide more glucose-lowering effect and more glucose loss in the urine, so it is typically used only after a doctor has assessed a patient’s needs, kidney function, and current response to treatment.

• Type 2 diabetes mellitus
• Improving blood sugar control
• Adjunct to diet and exercise
• Add-on therapy when one medicine is not enough
• May help reduce the need for separate diabetes tablets

• Swallow Empaone-L 25/5 Tablet whole with water; do not crush, split, or chew unless your doctor says otherwise.
• Take it exactly as prescribed, usually once daily at the same time each day.
• You may take it with or without food, but taking it consistently the same way each day can help.
• Drink enough fluids, especially if you have vomiting, diarrhea, or you are exercising or sweating a lot.
• If you miss a dose, take it when you remember unless it is almost time for the next dose; do not double up.
• Do not change from Empaone-L 10/5 Tablet to Empaone-L 25/5 Tablet on your own; the strength is different and your doctor should direct the switch.

Each Empaone-L 25/5 Tablet provides empagliflozin 25 mg plus linagliptin 5 mg per tablet, as labeled. It is generally taken once daily, and the maximum dose is usually one tablet per day unless your prescriber gives different instructions. Because this is the higher-strength version of the brand, your doctor decides whether Empaone-L 25/5 Tablet is appropriate for you rather than the lower 10/5 strength.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Empagliflozin + Linagliptin may include:

• Urination more often
• Thirst or dry mouth
• Stuffed or runny nose
• Sore throat
• Diarrhea
• Mild genital yeast infection symptoms
• Dizziness, especially if you are dehydrated

• This 25/5 tablet is a higher-strength option, so it should be used only if your doctor wants the stronger empagliflozin dose.
• Tell your clinician if you have kidney disease, because empagliflozin may not be appropriate in some kidney conditions.
• Use caution if you are older, take diuretics, or become dehydrated, because this medicine can lower blood pressure and cause dizziness.
• Limit heavy alcohol use, since it can raise the risk of dehydration and ketoacidosis.
• Seek advice before surgery or major fasting, because diabetes medicines may need temporary adjustment.
• Be alert for genital yeast infections and urinary tract infections, which can occur more often with empagliflozin.
• Do not use it to treat type 1 diabetes or diabetic ketoacidosis.

• Insulin and sulfonylureas may increase the risk of low blood sugar when used together.
• Diuretics can increase the risk of dehydration and low blood pressure.
• Rifampin may reduce linagliptin levels and affect how well the medicine works.
• Alcohol can worsen dehydration and raise the risk of ketoacidosis.
• Other diabetes medicines may need dose adjustment to avoid hypoglycemia.

Store Empaone-L 25/5 Tablet at room temperature in the original strip/box, away from moisture, heat, and direct light.